Osteoporosis in psoriatic arthritis: Is there any?

Wiener Klinische Wochenschrift

Volumn 123, Issue 23-24, 2011, Pages 743-750

  Grazio, Simeon ^a   Cvijetić, Selma ^b   Vlak, Tonko ^c   Grubišić, Frane ^a   Matijević, Valentina ^a   Nemčić, Tomislav ^a   Punda, Marija ^d   Kusić, Zvonko ^d  

^a KBC Zagreb   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

^d SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Arthritis; Disease activity; Osteoporosis; Prevalence; Psoriatic

Indexed keywords

C REACTIVE PROTEIN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTHESITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR NECK; FUNCTIONAL STATUS; HEALTH ASSESSMENT QUESTIONNAIRE; HIP; HUMAN; JOINT SWELLING; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; OSTEOPOROSIS; PATIENT ASSESSMENT; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; COMORBIDITY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84856976679     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-0095-8     Document Type: Article

References (59)

1. Laan RF, Buijs WC, Verbeek AL, Draad MP, Corstens FH, van de Putte LB, et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6. (Pubitemid 23018289)
2. Redlich K, Ziegler S, Kiener H P, Spitzauer S, Stohlawetz P, Bernecker P, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis 2000;59:308-10. (Pubitemid 30305576)
3. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005;32:1290-8. (Pubitemid 40995385)
4. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008;93:1952-8. (Pubitemid 351656543)
5. McLean R. Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep 2009;7:134-9.
6. Polzer K, Joosten L, Gasser J, Distler JH, Ruiz G, Baum W, et al. IL-1 is essential for systemic inflammatory bone loss. Ann Rheum Dis 2010;69:284-90.
7. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64:14-7.
8. Helliwell P, Taylor W. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005;64(suppl. 2): ii3-8. (Pubitemid 40288511)
9. Hofbauer LC, Schoppet M, Christ M, Teichmann J, Lange U. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Rheumatology 2006;45(10):1218-22. (Pubitemid 44542061)
10. Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001;28:138-43. (Pubitemid 32062037)
11. Reid DM, Kennedy NS, Nicoll J, Smith MA, Tothill P, Nuki G. Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 1986;5:372-8.
12. Grisar J, Bernecker PM, Aringer M, et al. Ankylosing Spondylitis, Psoriatic Arthritis, and Reactive Arthritis Show Increased Bone Resorption, But Differ with Regard to Bone Formation. J Rheumatol 2002;29:1430-6. (Pubitemid 34755610)
13. Harrison BJ, Hutchinson CE, Adams J, Bruce IN, Herrick AL. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 2002;61:1007-11. (Pubitemid 35221691)
14. Franck H. Komission Osteologie der Deutschen Gesellschaft für Rheumatologie, Braun J, Buttgereit F, Demary W, Hein G, Kekow J, Schett G, Kern PM. Bone densitometry in inflammatory rheumatic diseases: Characteristics of the measurement site and disease specific factors. Z Rheumatol 2009;68(10):845-50 [Article in German].
15. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
16. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van der Tempel H, Mielantset H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-32. (Pubitemid 36135387)
17. Van der Heijde D M F M, van't Hof MA, van Riel P L C M, van der Putte L B A. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81. (Pubitemid 23102498)
18. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
19. Ramey DR, Raynauld JP, Fries J F. The health assessment questionnaire 1992: status and review Arthritis Care Res 1992;5:119-29.
20. Blackmore M, Gladman DD, Husted J, Long J, Farewell V T. Measuring health status in psoriatic arthritis: The Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
21. WHO. Report of a WHO Study Group, World Health Organ Tech Rep Ser 843, 1994.
22. Cvijetić S, Koršić M. Apparent bone mineral density estimated from DXA in healthy men and women. Osteoporos Int 2004;15:295-300. (Pubitemid 38543948)
23. Grazio S, Koršić M, Jajić I. Prevalence of vertebral fractures in an urban population in Croatia aged fifty and older. Wien Klin Wochenschr 2005;117:42-7. (Pubitemid 40546360)
24. National Women Health Information Center (NWHIC) (http://www. womenshealth.gov/index.cfm). US Department of Health and Human Services. Last Updated: February, 2011.
25. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D. Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 2007;18(1):77-84. (Pubitemid 44885498)
26. Scheidt-Nave C, Starker A. The prevalence of osteoporosis and associated health care use in women 45 years and older in Germany. Results of the first German Telephone Health Survey 2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005;48(12):1338-47 [Article in German]. (Pubitemid 43118709)
27. Dreiher J, Weitzman D, Cohen AD. Psoriasis and Osteoporosis: A Sex-Specific Association? J Invest Dermatol 2009;129:1643-9.
28. Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker J N W N. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001;26:446-8. (Pubitemid 32863103)
29. Borman P, Babaoǧlu S, Gur G, Bingol S, Bodur H. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rhumatol 2008;27(4):443-7. (Pubitemid 351404298)
30. Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 2011;13:R16.
31. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008;93:1952-8. (Pubitemid 351656543)
32. Koh J, Khang Y, Jung C, Bae S, Kim D, Chung Y, Kim G. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre-and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005;16:1263-71. (Pubitemid 41396955)
33. Barnabe C, Hanley DA. Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum 2009;39:116-22.
34. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-9. (Pubitemid 129516268)
35. Gladman DD. Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis 2006;65(Suppl. III): iii22-4. (Pubitemid 44629096)
36. Braun J, Baraliakos X, Golder W, et al. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 2004;63:1046-55. (Pubitemid 39120353)
37. Ghozlani I, Ghazi M, Nouijai A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009;44:772-6.
38. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005;32:1290-8. (Pubitemid 40995385)
39. Toussirot E, Wendling D. Bone mass in ankylosing sponylitis. Clin Exp Rheumatol 2000;18(suppl. 21): S16-20.
40. Borman P. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2004;24:59-60. (Pubitemid 38168119)
41. El Maghraoui A. Osteoporosis and ankylosing spondylitis. Joint Bone Spine 2004;71:291-5. (Pubitemid 39037316)
42. Grazio S, Kusić Z, Cvijetić S, et al. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 2011. doi: 10.1007/s00296-011-2066-9
43. Capaci K, Hepguler S, Argin M, Tas I. Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med J 2003;44(3):379-84. (Pubitemid 36833888)
44. Haugeberg G, Ørstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 2003;15:469-75. (Pubitemid 36774261)
45. Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
46. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 2000;43:522-30.
47. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Reduced bone mineral density in male rheumatoid arthritis patients. Arthritis Rheum 2000;43:2776-84.
48. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 2001;40:882-8.
49. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009;44:772-6.
50. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6. (Pubitemid 32726931)
51. Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof Łacki J. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? Clin Rheumatol 2008, 27:565-72. (Pubitemid 351494011)
52. Mease P, Antoni C, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64(suppl. 2): ii49-54. (Pubitemid 40288522)
53. Kwok T, Pope JE. Minimally important difference for patientreported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global Visual Analog Scales. J Rheumatol 2010;37:1024-8.
54. Fransen J, Antoni C, Mease PJ, et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomized controlled trials of two tumor necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8. (Pubitemid 44620449)
55. Taccari E, Sensi F, Spadaro A, Riccieri V, Rinaldi T. Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritis. Osteoporos Int 2001;12:412-6. (Pubitemid 32606467)
56. Dheda K, Cassim B, Patel N, Mody GM. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin Rheumatol 2004;23:89. (Pubitemid 38247984)
57. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7. (Pubitemid 24199420)
58. Haugeberg G, Strand A, Kvien TK, Kirwan JR. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo controlled trial. Arch Intern Med 2005;165:1293-7. (Pubitemid 40989595)
59. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 2006;166:2495-501. (Pubitemid 44913235)